30 results on '"Erstad, Brian"'
Search Results
2. Evolution of critical care pharmacy practice: A study to remember.
- Author
-
Erstad, Brian L.
- Subjects
CRITICAL care medicine ,PHARMACY ,HEALTH care teams ,MEDICAL care - Abstract
The article discusses the evolution of critical care pharmacy practice and the acceptance of critical care pharmacists by their colleagues. It highlights the importance of a landmark study by Leape et al. published in 1999, which demonstrated the value of pharmacists in preventing adverse drug events (ADEs) in the ICU setting. The study found that involving a pharmacist in ICU rounding significantly reduced preventable ADEs. This study, along with other publications and consensus recommendations, has helped establish the role and value of critical care pharmacists in medication optimization and patient safety. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
3. Critical Care Pharmacist Attitudes and Perceptions of Neuromuscular Blocker Infusions in ARDS.
- Author
-
Devlin, John W., Train, Sarah E., Burns, Karen E. A., Massaro, Anthony, Wu, Ting Ting, Castor, Timothy, Vassaur, John, Selvan, Kavitha, Kress, John P., and Erstad, Brian L.
- Subjects
PHARMACISTS' attitudes ,CRITICALLY ill ,PHARMACIST-patient relationships ,CRITICAL care medicine ,ADULT respiratory distress syndrome ,INTENSIVE care units ,MUSCLE weakness - Abstract
Background: Current critical care pharmacist (CCP) practices and perceptions related to neuromuscular infusion (NMBI) use for acute respiratory distress syndrome (ARDS) maybe different with the COVID-19 pandemic and the publication of 2020 NMBI practice guidelines. Objective: To evaluate CCP practices and perceptions regarding NMBI use for patients with moderate-severe ARDS. Methods: We developed, tested, and electronically administered a questionnaire (7 parent-, 42 sub-questions) to 409 American College of Clinical Pharmacy (ACCP) Critical Care Practice and Research Network members in 12 geographically diverse states. The questionnaire focused on adults with moderate-severe ARDS (PaO
2 :FiO2 <150) whose causes of dyssynchrony were addressed. Two reminders were sent at 10-day intervals. Results: Respondents [131/409 (32%)] primarily worked in a medical intensive care unit (ICU) 102 (78%). Compared to COVID-negative(-) ARDS patients, COVID positive(+) ARDS patients were twice as likely to receive a NMBI (34 ± 18 vs.16 ± 17%; P < 0.01). Respondents somewhat/strongly agreed a NMBI should be reserved until after trials of deep sedation (112, 86%) or proning (92, 81%) and that NMBI reduced barotrauma (88, 67%), dyssynchrony (87, 66%), and plateau pressure (79, 60%). Few respondents somewhat/strongly agreed that a NMBI should be initiated at ARDS onset (23, 18%) or that NMBI reduced 90-day mortality (12, 10%). Only 2/14 potential NMBI risks [paralysis awareness (101, 82%) and prolonged muscle weakness (84, 68%)] were frequently reported to be of high/very high concern. Multiple NMBI titration targets were assessed as very/extremely important including arterial pH (109, 88%), dyssynchrony (107, 86%), and PaO2 : FiO2 ratio (82, 66%). Train-of-four (55, 44%) and BIS monitoring (36, 29%) were deemed less important. Preferred NMBI discontinuation criteria included absence of dysschrony (84, 69%) and use ≥48 hour (72, 59%). Conclusions and Relevance: Current critical care pharmacists believe NMBI for ARDS patients are best reserved until after trials of deep sedation or proning; unique considerations exist in COVID+ patients. Our results should be considered when ICU NMBI protocols are being developed and bedside decisions regarding NMBI use in ARDS are being formulated. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
4. Peripheral intravenous administration of 23.4% sodium chloride solution: A plea for caution.
- Author
-
Erstad, Brian L
- Subjects
- *
INTRAVENOUS catheterization , *INTRAVENOUS therapy , *INTRACRANIAL pressure , *CRITICAL care medicine , *HYPERTONIC saline solutions , *BRAIN injuries , *CEREBRAL edema , *PATIENT safety - Abstract
The authors examine the intravenous administration of 23.4% hypertonic sodium solutions for the management of severe traumatic brain injury. They discuss a review article that discussed controversies and warnings related to the administration of 23.4% sodium chloride in life-threatening situations, as well as a retrospective study supporting peripheral administration that was available at the time of their review. The authors advise practicing caution when considering the treatment approach.
- Published
- 2023
- Full Text
- View/download PDF
5. Normal saline or balanced salt solutions for fluid administration with a focus on critical care and emergency medicine settings.
- Author
-
Erstad, Brian L
- Subjects
- *
LENGTH of stay in hospitals , *CRITICAL care medicine , *BLOOD plasma substitutes , *DECISION making in clinical medicine , *PHYSIOLOGIC salines , *EMERGENCY medicine - Abstract
The article provides an overview of key clinical trials comparing normal saline (NS) and balanced salt solutions (BSS). Topics include concerns over potential adverse effects from chloride-replacement anions commonly found in BSS, general prescribing considerations for NS and BSSs, and considerations for using NS and BSS.
- Published
- 2022
- Full Text
- View/download PDF
6. Critical care essentials for pharmacy trainees and new clinical practitioners.
- Author
-
Erstad, Brian L, Kiser, Tyree H, and Bauer, Seth R
- Subjects
- *
INTERNSHIP programs , *MEDICAL protocols , *CRITICAL care medicine , *NURSES , *INFORMATION resources , *TEACHING aids - Abstract
The article recommends several publications related to critical care pharmacy practice. Topics discussed include the articles that offer a historical background of critical care pharmacists and pharmacy services, significance of the creation of the Board Certified Critical Care Pharmacist (BCCCP) program in 2013, and opportunities for awareness and discussion of articles on critical care pharmacy offered by podcasts such as the series "Pharmacy to Dose: The Critical Care Podcast."
- Published
- 2021
- Full Text
- View/download PDF
7. Justification of the value of critical care pharmacists: Still a work in progress?
- Author
-
Erstad, Brian L
- Subjects
- *
CRITICAL care medicine , *HOSPITAL pharmacies , *WORKING hours , *INTERNSHIP programs , *MEDICAL care , *PATIENTS , *SCHOLARSHIPS , *OCCUPATIONAL roles , *TEACHING methods - Abstract
The article examines the value of critical care pharmacists as members of multidisciplinary critical care teams. It examines their involvement in patient care, teaching and training, and scholarship. It suggests the growing value of pharmacists as researchers, the need for board certification to become residency program directors, and demand for more studies for their staffing needs and prioritization of activities.
- Published
- 2020
- Full Text
- View/download PDF
8. Clinical Pharmacist-Led Impact on Inappropriate Albumin Use and Costs in the Critically Ill.
- Author
-
Buckley, Mitchell S., Knutson, Kristen D., Agarwal, Sumit K., Lansburg, Jake M., Wicks, Laura M., Saggar, Rajeev C., Richards, Emily C., Kopp, Brian J., and Erstad, Brian L.
- Subjects
ALBUMINS ,INTENSIVE care units ,PHARMACISTS ,PATIENTS ,IMPLEMENTATION (Social action programs) ,DRUG utilization statistics ,ACADEMIC medical centers ,COST control ,RETROSPECTIVE studies ,INAPPROPRIATE prescribing (Medicine) ,HOSPITAL mortality ,CATASTROPHIC illness ,CRITICAL care medicine ,DRUG utilization - Abstract
Background:Optimal albumin use in the intensive care unit (ICU) remains challenging with inappropriate use approaching 50%. No published reports have described clinical pharmacist impact aimed at mitigating inappropriate albumin use in the ICU. Objective: To evaluate the clinical and economic impact of a clinical pharmacist-led intervention strategy targeting inappropriate albumin in the ICU. Methods: A retrospective cohort study evaluated all adult (≥18 years) ICU patients administered albumin at an academic medical center over a 2-year period. Institutional guidelines were developed with clinical pharmacists targeting inappropriate albumin use. The primary end point was to compare inappropriate use of albumin administered before and after pharmacist intervention implementation. Secondary analyses compared the overall albumin use between study periods. In-hospital mortality, length of stay, and albumin-related costs between study periods were also compared. Results: A total of 4419 patients were identified, with 2448 (55.4%) critically ill patients included. The pharmacist-led strategy resulted in a 50.9% reduction of inappropriate albumin use (P < 0.001). The rate of inappropriate albumin use was 44.3 ± 10.5 and 5.5 ± 2.9 g per patient-day in the preimplementation and postimplementation periods, respectively (P < 0.001). Costs associated with overall and inappropriate albumin use in the ICU decreased by 34.8% and 87.1%, respectively. Total annual cost-savings was $355 393 in the ICUs. No differences in clinical outcomes were found. Conclusion and Relevance: Clinical pharmacist-led interventions reduced overall and inappropriate albumin use and costs without negatively affecting clinical outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
9. Developing a Business Plan for Critical Care Pharmacy Services.
- Author
-
Erstad, Brian L., Mann, Henry J., and Weber, Robert J.
- Subjects
- *
BUSINESS , *CRITICAL care medicine , *HOSPITAL pharmacies , *INTENSIVE care units - Abstract
Critical care medicine has grown from a small group of physicians participating in patient care rounds in surgical and medical intensive care units (ICUs) to a highly technical, interdisciplinary team. Pharmacy's growth in the area of critical care is as exponential. Today's ICU requires a comprehensive pharmaceutical service that includes both operational and clinical services to meet patient medication needs. This article provides the elements for a business plan to justify critical care pharmacy services by describing the pertinent background and benefit of ICU pharmacy services, detailing a current assessment of ICU pharmacy services, listing the essential ICU pharmacy services, describing service metrics, and delineating an appropriate timeline for implementing an ICU pharmacy service. The structure and approach of this business plan can be applied to a variety of pharmacy services. By following the format and information listed in this article, the pharmacy director can move closer to developing patient-centered pharmacy services for ICU patients. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
10. Caring for the COVID Patient: A Clinical Pharmacist's Perspective.
- Author
-
Erstad, Brian L.
- Subjects
COVID-19 treatment ,COVID-19 pandemic ,PATIENT care ,CRITICAL care medicine ,INTENSIVE care units - Abstract
Physicians and nurses have received many accolades in commercial and scientific media for their heroic efforts in caring for patients with COVID-19. These accolades are appropriate and deserved. However, there are a number of clinical pharmacists involved in the daily care of patients who are caring and competent practitioners, and also deserve our thanks and praise. The purpose of this article is to provide the impactful comments of a front-line, critical care pharmacist dedicated to providing the best possible care for patients with COVID-19 in a medical intensive care unit. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Response to Murray et al.
- Author
-
Erstad, Brian L
- Subjects
- *
CLINICAL medicine research , *CRITICAL care medicine , *INTERPROFESSIONAL relations - Published
- 2022
- Full Text
- View/download PDF
12. Adverse effects of nonsteroidal anti-inflammatory drugs in critically ill patients: A scoping review.
- Author
-
Martin, Jennifer R, Yu, Madeline, and Erstad, Brian L
- Subjects
- *
DRUG side effects , *ONLINE information services , *MEDICAL databases , *PERIOPERATIVE care , *MEDICAL information storage & retrieval systems , *CRITICALLY ill , *NONSTEROIDAL anti-inflammatory agents , *GASTROINTESTINAL hemorrhage , *SYSTEMATIC reviews , *PATIENTS , *SURGERY , *RISK assessment , *CATASTROPHIC illness , *CRITICAL care medicine , *LITERATURE reviews , *MEDLINE , *ACUTE kidney failure , *DISEASE risk factors - Abstract
Purpose Nonsteroidal anti-inflammatory drugs (NSAIDs) are often recommended as opioid-sparing agents. The objective of this scoping review was to conduct a thorough search of the current literature to determine whether in adult critically ill patients there is an association between exposure to NSAIDs vs no NSAIDs and the subsequent development of serious adverse events, particularly gastrointestinal bleeding and acute kidney injury (AKI). Methods The Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension for Scoping Reviews was utilized as a guideline for reporting. Searches were performed in PubMed (National Library of Medicine), Cochrane Library (Wiley), EMBASE (Elsevier), Stat!Ref (Teton), and Access Pharmacy (McGraw Hill) for articles published from January 2016 to August 2022. Results Of the 3,062 citations and titles identified in the search, 2,737 titles remained after removal of duplicates, 2,588 were excluded at title and abstract screening, and 149 articles remained for full-text review. None of the studies involved heterogeneous groups of critically ill patients in nonspecialty intensive care unit settings. Most studies evaluated were conducted in the perioperative setting and had limited adverse events reporting, particularly with respect to serious NSAID-related adverse effects of concern in critically ill patients. Conclusion In published studies primarily involving perioperative patients, there is insufficient detail concerning the definitions and reporting of NSAID-related serious adverse events such as bleeding and AKI. These events are of particular concern in heterogeneous critically ill patient populations predisposed to such complications. In most (if not all) critically ill patients, sustained dosing of NSAIDs should be avoided regardless of COX-1 selectivity due to the paucity of safety data. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. Interdisciplinary Patient Care in the Intensive Care Unit: Focus on the Pharmacist.
- Author
-
Erstad, Brian L., O'Keeffe, Terence, Hokula, Cheryl A., Parrinello, Kathleen, Theodorou, Andreas A., and Haas, Curtis E.
- Subjects
- *
CRITICAL care medicine , *INTENSIVE care units , *PHARMACISTS , *PHARMACIST-patient relationships , *PHARMACY , *LEADERSHIP - Abstract
The field of critical care medicine began to flourish only within the last 40 years, yet it provides some of the best examples of collaborative pharmacy practice models and evidence for the value of pharmacist involvement in interdisciplinary practice. This collaborative approach is fostered by critical care organizations that have elected pharmacists into leadership positions and recognized pharmacists through various honors. There is substantial literature to support the value of the critical care pharmacist as a member of an interdisciplinary intensive care unit (ICU) team, particularly in terms of patient safety. Furthermore, a number of economic investigations have demonstrated cost savings or cost avoidance with pharmacist involvement. As the published evidence supporting pharmacist involvement in patient care activities in the ICU setting has increased, surveys have demonstrated an increase in the percentage of pharmacists performing clinical activities. In addition, substantial support of pharmacists has been provided by other clinicians, safety officers, and administrative personnel who have been involved with the initiation and expansion of critical care pharmacy services in their own institutions. Although there is still room for improvement in the range of pharmacist involvement, particularly with respect to interdisciplinary activities related to education and scholarship, pharmacists have become essential members of interdisciplinary care teams in ICU settings. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
14. Pain Management Within the Palliative and End-of-Life Care Experience in the ICU.
- Author
-
Mularski, Richard A., Puntillo, Kathleen, Varkey, Basil, Erstad, Brian L., Crap, Mary Jo, Gilbert, Hugh C., Li, Denise, Medina, Justine, Pasero, Chris, and Sessler, Curtis N.
- Subjects
PAIN management ,TERMINAL care ,PALLIATIVE treatment ,INTENSIVE care units ,MEDICAL care ,CRITICAL care medicine - Abstract
The article discusses the concept of pain management within the palliative and end-of-life experience in the intensive care unit (ICU). It states that high pain management requires skill in phamacologic, behavioral, social and communication strategies in the holistic palliative care approach. It evaluates the experience of patients at ICU, patient who with beneficial treatment of healthcare team. Moreover, it explores also the impact of comprehensive palliative care.
- Published
- 2009
- Full Text
- View/download PDF
15. Pain Management Principles in the Critically III.
- Author
-
Erstad, Brian L., Puntillo, Kathleen, Gilbert, Hugh C., Crap, Mary Jo, Li, Denise, Medina, Justine, Mularski, Richard A., Pasero, Chris, Varkey, Basil, and Ses, Curtis N.
- Subjects
- *
CRITICAL care medicine , *INTENSIVE care units , *DRUG therapy , *OPIOIDS , *PAIN management ,ANALGESIC effectiveness - Abstract
The article presents a study on the conventional pharmacologic and non-pharmacologic pain treatment in patients admitted in intensive care units (ICUs). The study examined the effectiveness of opioid analgesics which are cited to have been the mainstay to control pain. It proposed various alternative medications to the opioids for pain control and investigated their effectivity in the critically ill patient. It showed that the effectiveness of nonpharmacologic therapies in ICUs is limited.
- Published
- 2009
- Full Text
- View/download PDF
16. Evaluation of Pain in ICU Patients.
- Author
-
Puntillo, Kathleen, Pasero, Chris, Li, Denise, Mularski, Richard A., Crap, Mary Jo, Erstad, Brian L., Varkey, Basil, Gilbert, Hugh C., Medina, Justine, and Sessler, Curtis N.
- Subjects
MEDICAL care ,INTENSIVE care units ,PAIN management ,CRITICAL care medicine ,MEDICAL care research - Abstract
The article focuses on assessing and evaluating the pain in intensive care unit (ICU) patients in the U.S. It features the pain behavior instruments that have been tested for their reliability, validity, and feasibility of use in ICUs, the pain behavior scale and the Critical-Care Pain Observation Tool. It also discusses the alternative methods of augmenting a pain evaluation including completion of pain risk profile, use of surrogates, or performance of an analgesic trial.
- Published
- 2009
- Full Text
- View/download PDF
17. Definitive Care for the Critically Ill During a Disaster: Medical Resources for Surge Capacity.
- Author
-
Rubinson, Lewis, Hick, John L., Curtis, J. Randall, Branson, Richard D., Burns, Suzi, Christian, Michael D., Devereaux, Asha V., Dichter, Jeffrey R., Talmor, Daniel, Erstad, Brian, Medina, Justine, and Geiling, James A.
- Subjects
CONFERENCES & conventions ,MEDICAL personnel ,CRITICAL care medicine ,EMERGENCY medicine ,MEDICAL care conferences - Abstract
Information is presented about several papers discussed at a summit on the Task Force for Mass Critical Care sponsored by members of Critical Care Collaborative. Topics included recommended model in giving limited, essential critical care known as emergency mass critical care (EMCC), including its suggested medical equipment, concepts to widen treatment spaces and staffing models for EMCC. The summit featured several experts in emergency and medical care services.
- Published
- 2008
- Full Text
- View/download PDF
18. Pharmacologic Management of Constipation in the Critically Ill Patient.
- Author
-
Patanwala, Asad E., Abarca, Jacob, Huckleberry, Yvonne, and Erstad, Brian L.
- Subjects
LAXATIVES ,CRITICALLY ill ,CONSTIPATION ,CRITICAL care medicine ,LOGISTIC regression analysis ,OPIOIDS - Abstract
Study Objective. To compare the effectiveness of common laxatives in producing a bowel movement in patients admitted to a medical intensive care unit (M1CU). Design. Retrospective medical record review. Setting. MICU of an academic medical center. Patients. Ninety-five patients admitted to the MICU from July 1-October 31, 2004. Measurements and Main Results. Fifty patients satisfied the inclusion criteria. Patient-specific data such as age, weight, sex, length of MICU stay, Acute Physiology and Chronic Health Evaluation (APACHE) II score, dietary intake, opioid intake, laxative intake, and bowel movements were recorded during the first 96 hours of admission. Logistic regression analysis was used to compare patients who did and did not have a bowel movement. Of the 50 patients, 25 did not have a bowel movement during the first 96 hours of M1CU admission. Patients given a stimulant laxative (senna, bisacodyl) and/or an osmotic laxative (lactulose, milk of magnesia) were more likely to have a bowel movement (odds ratio [OR] 26.6, 95% confidence interval [CI] 3.2-221, p=0.002). Opioid intake, expressed as logarithmic morphine equivalents, was negatively associated with occurrence of a bowel movement (OR 0.76, 95% C1 0.59-0.97, p=0.027). Disease severity, as determined by APACHE I1 score, was also negatively associated with a bowel movement (OR 0.84, 95% CI 0.7-0.99, p=0.04). Conclusion. Critically ill patients have a high frequency of constipation, and opioid therapy is a significant risk factor. Routine administration of stimulant or osmotic laxatives should be considered for this patient population. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
19. Key Articles and Guidelines Relative to Intensive Care Unit Pharmacology--2004.
- Author
-
Erstad, Brian L., Martin, Steven J., Brophy, Gretchen M., Haas, Curtis E., Jacobi, Judith, Welage, Lynda S., and Thomas, Michael C.
- Subjects
- *
THERAPEUTICS , *DRUGS , *CRITICAL care medicine , *PHARMACISTS , *MEDICAL personnel - Abstract
Compilations of key articles and guidelines in a particular clinical practice area are useful not only to clinicians who practice in that area, but to all clinicians. We compiled pertinent articles and guidelines pertaining to drug therapy in the intensive care setting from the perspective of actively practicing critical care pharmacists. This document differs from the original 2002 version in that a broader assembly of intensive care practitioners was involved in the compilation. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
20. Dosing of medications in morbidly obese patients in the intensive care unit setting.
- Author
-
Erstad, Brian L.
- Subjects
- *
OVERWEIGHT persons , *INTENSIVE care units , *MEDLINE , *PHARMACOKINETICS , *OBESITY , *DRUG dosage , *THERAPEUTIC use of narcotics , *FIBRINOLYTIC agents , *ANALGESICS , *ANTI-infective agents , *ANTICOAGULANTS , *ANTICONVULSANTS , *BIOTRANSFORMATION (Metabolism) , *BODY weight , *CARDIOVASCULAR agents , *CRITICAL care medicine , *DRUG interactions , *DRUG monitoring , *DRUG administration , *GASTROINTESTINAL agents , *MEDICAL protocols , *NARCOTICS , *RESPIRATION , *MORBID obesity , *PHARMACODYNAMICS , *THERAPEUTICS ,THERAPEUTIC use of fibrinolytic agents - Abstract
Objective: To derive recommendations for the dosing of commonly used medications in the morbidly obese patient in the ICU.Data Sources: Articles were obtained through computerized searches involving MEDLINE. The bibliographies of retrieved publications and textbooks were reviewed for additional references.Study Selection: All studies involving the pharmacokinetics or pharmacodynamics of medications in obese subjects or patients.Data Extraction: The emphasis was on studies involving morbidly obese patients but, in the absence of such data, investigations involving lesser forms of obesity were extracted.Data Synthesis: There is a paucity of data upon which to make recommendations for dosing commonly used medications in the morbidly obese patient in the ICU, although recommendations were provided based on the available information.Conclusions: There is clearly a need for more investigations involving dosing regimens of medications in the morbidly obese population. Until such studies are available, the clinician must try to derive the best dosing regimens for medications based on the limited pharmacokinetic data available for some agents and clinical judgement. [ABSTRACT FROM AUTHOR]- Published
- 2004
- Full Text
- View/download PDF
21. Medication administration errors in adult patients in the ICU.
- Author
-
Calabrese, Andrea D., Erstad, Brian L., Brandl, Katherine, Barletta, Jeffrey F., Kane, Sandra L., and Sherman, Deb S.
- Subjects
MEDICATION errors ,MEDICAL errors ,DRUG administration ,CRITICAL care medicine ,MEDICINE - Abstract
Objective: To quantify the incidence and specify the types of medication administration errors from a list of error-prone medications and to determine if patient harm resulted from these errors. Design: An observational evaluation. Setting: Five intensive care units (ICUs) in the United States. Patients and participants: Eight hundred fifty-one patients who were at least 18 years of age and admitted to surgical, medical or mixed ICUs during a 3 month period were included. Interventions: None. Measurements and results: A list of error-prone medications was adapted from the literature and evaluated for medication errors and patient harm. Of 5,744 observations in 851 patients, 187 (3.3%) medication administration errors were detected. the therapeutic classes most commonly associated with errors were vasoactive drugs 61 (32.6%) and sedative/analgesics 48 (25.7%). The most common type of error was wrong infusion rate with 71 (40.1%) errors. Twenty-one errors did not reach the patient and 159 reached the patient but did not result in harm, increased monitoring or intervention. Five errors required increased patient monitoring and two required intervention. None of the errors resulted in patient death. Conclusions: This multicenter evaluation found fewer medication administration errors than the published literature, possibly due to the varying observational techniques and pharmacist involvement. Lorazepam and wrong infusion rates are associated with errors that occurred frequently, resulted in the greatest potential for harm and were common oversights in the system. These errors should be considered potential areas for betterment in the medication use process to improve patient safety. [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
22. Cost savings with interventions to reduce aerosolized bronchodilator use in mechanically ventilated patients.
- Author
-
Camamo, James M., Weibel, Kurt, O'Keeffe, Terence, Diven, Conrad, and Erstad, Brian L.
- Subjects
ACADEMIC medical centers ,AEROSOLS ,ARTIFICIAL respiration ,BRONCHODILATOR agents ,CHI-squared test ,CRITICAL care medicine ,CLINICAL drug trials ,MEDICAL care ,PATIENTS ,DATA analysis ,RETROSPECTIVE studies ,DATA analysis software ,DESCRIPTIVE statistics - Published
- 2014
- Full Text
- View/download PDF
23. Obesity in critical illness: What weight or why weight?
- Author
-
Erstad, Brian L.
- Subjects
- *
OBESITY , *HEALTH outcome assessment , *BODY mass index , *CRITICALLY ill , *CRITICAL care medicine , *MEDICAL care - Abstract
The author reflects on the study which examines the association between obesity, processes of care and the outcomes for critically ill patients. He considers the use of fluid-adjusted body mass index (BMI) and the processes of care as the strengths of the study. He outlines the factors considered in the process of care which include sedative use and ventilatory parameters.
- Published
- 2012
- Full Text
- View/download PDF
24. Methods used to attribute costs avoided from pharmacist interventions in acute care: A scoping review.
- Author
-
Narayan, Sujita W, Abraham, Ivo, Erstad, Brian L, Haas, Curtis E, Sanders, Arthur, and Patanwala, Asad E
- Subjects
- *
MEDICAL information storage & retrieval systems , *SYSTEMATIC reviews , *DRUGSTORES , *COST control , *MEDICATION errors , *MEDICATION therapy management , *COST analysis , *CRITICAL care medicine , *DESCRIPTIVE statistics , *LITERATURE reviews , *MEDLINE , *DRUG side effects , *PATIENT safety - Abstract
Purpose Cost-avoidance studies are common in pharmacy practice literature. This scoping review summarizes, critiques, and identifies current limitations of the methods that have been used to determine cost avoidance associated with pharmacists' interventions in acute care settings. Methods An Embase and MEDLINE search was conducted to identify studies that estimated cost avoidance from pharmacist interventions in acute care settings. We included studies with human participants and articles published in English from July 2010 to January 2021, with the intent of summarizing the evidence most relevant to contemporary practice. Results The database search retrieved 129 articles, of which 39 were included. Among these publications, less than half (18 of 39) mentioned whether the researchers assigned a probability for the occurrence of a harmful consequence in the absence of an intervention; thus, a 100% probability of a harmful consequence was assumed. Eleven of the 39 articles identified the specific harm that would occur in the absence of intervention. No clear methods of estimating cost avoidance could be identified for 7 studies. Among all 39 included articles, only 1 attributed both a probability to the potential harm and identified the cost specific to that harm. Conclusion Cost-avoidance studies of pharmacists' interventions in acute care settings over the last decade have common flaws and provide estimates that are likely to be inflated. There is a need for guidance on consistent methodology for such investigations for reporting of results and to confirm the validity of their economic implications. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
25. Colloids and renal dysfunction: Another brick in the wall of safety concerns.
- Author
-
Erstad, Brian L.
- Subjects
- *
COLLOIDS , *KIDNEY diseases , *ALBUMINS , *SEPSIS , *CRITICAL care medicine - Abstract
The author expresses his views on colloids and renal dysfunction in relation to a study conducted by researcher O. Bayer and colleagues, published in a 2011 issue of the journal "Critical Care Medicine." The study focused on the renal impact of synthetic colloids and crystalloids on patients with severe sepsis. Results of the study revealed the association between hyperoncotic albumin and the rates of acute kidney injury and renal replacement therapy in multiple logistic regression analysis.
- Published
- 2011
- Full Text
- View/download PDF
26. Quality of critical care clinical practice guidelines involving pharmacotherapy recommendations.
- Author
-
Edwards, Christopher, Lam, Jonathan, Gardiner, Jordan, and Erstad, Brian L
- Subjects
- *
MEDICAL quality control , *OCCUPATIONAL roles , *ONLINE information services , *MEDICAL information storage & retrieval systems , *CONFIDENCE intervals , *SYSTEMATIC reviews , *MEDICAL protocols , *CRITICAL care medicine , *DRUG therapy , *MEDLINE , *PHARMACEUTICAL industry - Abstract
Purpose To assess the quality of critical care clinical practice guidelines (CPGs) involving pharmacotherapy recommendations. Methods A systematic electronic search was performed using PubMed, MEDLINE, and Embase for critical care CPGs published between 2012 and 2022 and involving pharmacotherapy recommendations. The Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument was employed to appraise CPG quality through independent assessment by 2 appraisers. Results Twenty-one CPGs were evaluated. The number of recommendations in each guideline ranged from 2 to 250, with a total of 1,604 recommendations. The number of strong (vs weak) recommendations in each guideline ranged from 0 to 31, with a total of 116 strong recommendations, or 7.23% of the total number of recommendations. There was at least 1 pharmacist author for 9 (43%) of the guidelines. The AGREE II domains for which mean quality scores of evaluated guidelines were highest were scope and purpose (0.88; 95% CI, 0.85-0.92), rigor of development (0.80; 95% CI, 0.77-0.83), clarity of presentation (0.84; 95% CI, 0.81-0.87), and editorial independence (0.86; 95% CI, 0.79-0.94), while those for which mean scores were lowest were stakeholder involvement (0.69; 95% CI, 0.63-0.75) and applicability (0.49; 95% CI, 0.43-0.55). Involvement of a pharmacist in CPG development was associated with significantly higher scoring for stakeholder involvement (P = 0.0356). Conclusion Strong recommendations accounted for less than 10% of the recommendations in the evaluated CPGs. Moreover, there are concerns related to guideline applicability (ie, advice or tools for putting recommendations into practice) and stakeholder involvement (ie, inclusion of individuals from all relevant groups). It is important to involve pharmacists in CPGs with pharmacotherapy recommendations. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
27. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient: 2016 update--executive summary.
- Author
-
Murray, Michael J., DeBlock, Heidi F., Erstad, Brian L., Gray Jr., Anthony W., Jacobi, Judith, Jordan, Ché J., McGee, William T., McManus, Claire, Meade, Maureen O., Nix, Sean A., Patterson, Andrew J., and Sands, Karen
- Subjects
- *
CRITICAL care medicine , *CRITICALLY ill , *NEUROMUSCULAR blocking agents , *PATIENTS , *EVIDENCE-based medicine , *PROFESSIONAL practice - Abstract
The article presents an update on expert recommendations on the use of neuromuscular blocking agents (NMBA) in critically ill adult patients for 2016. Topics covered include scheduled eye care for patients receiving continuous infusions with NMBA, NMBA administration in patients undergoing therapeutic hypothermia, implementation of measures to attenuate the risk of unintended extubation and the use of analgesic and sedative drugs before and during neuromuscular blockade.
- Published
- 2017
- Full Text
- View/download PDF
28. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
- Author
-
Kopp, Brian J., Mrsan, Melinda, Erstad, Brian L., and Duby, Jeremiah J.
- Subjects
- *
CRITICAL care medicine , *PEDIATRIC intensive care , *SURGICAL intensive care , *SURGICAL therapeutics - Abstract
Purpose. The cost implications of and potential adverse events prevented by the interventions of a critical care pharmacist were studied. Methods. A decentralized clinical pharmacist assigned to a surgical intensive care unit (ICU) documented all interventions made from mid-October 2003 through February 2004 using a standardized written form. The data were retrospectively evaluated and the following information was extracted: amount of time spent performing various clinical activities, how drug-related problems were identified (e.g., order entry versus chart review), and a general description of the interventions. The interventions were independently reviewed by two other clinical pharmacists to determine whether an actual or potential adverse drug event (ADE) would have occurred without the intervention, the probability that an ADE would have occurred without the intervention, the type of intervention, and potential cost avoidance of the intervention. Once the evaluations were completed, the data obtained from order entry and verification activities were compared with the data obtained during other clinical functions. Results. A total of 129 interventions were documented over 4.5 months. The majority of interventions were identified during chart review (40%) and patient care rounds (39%). The potential cost avoidance of the documented interventions was $205,919-$280,421. Interventions identified during patient care rounds and chart review were most likely to achieve the greatest impact on cost avoidance. Conclusion. Among the interventions performed and documented by a clinical pharmacist in an ICU, patient care rounds and chart-review activities were associated with the greatest number of interventionsand the greatest potential cost avoidance. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
29. Development of the Critical Care Pharmacotherapy Trials Network.
- Author
-
Bauer, Seth R., Abraham, Prasad E., Barletta, Jeffrey F., Brophy, Gretchen M., Erstad, Brian L., Gonzales, Jeffrey P., Haas, Curtis E., MacLaren, Robert, Mueller, Eric W., Olsen, Keith M., and Lat, Ishaq
- Subjects
- *
PHARMACOLOGY , *CRITICAL care medicine , *PROFESSIONAL associations , *BUSINESS networks , *CLINICAL medicine research , *COMMITTEES , *ENDOWMENTS , *INTERNATIONAL relations , *INTERPROFESSIONAL relations , *ORGANIZATIONAL structure , *MEMBERSHIP , *RESEARCH personnel , *ORGANIZATIONAL goals , *SOCIETIES - Abstract
Purpose. The development of the Critical Care Pharmacotherapy Trials Network (CCPTN) as a model for practice-based pharmacotherapy research is described. Summary. The CCPTN was formed in 2010 as a collaborative research network dedicated to scientific investigation in the field of critical care pharmacotherapy. The CCPTN organizational structure is consistent with many professional pharmacy and interdisciplinary organizations and organized into 3 primary domains: executive committee, working committees, and network membership. The network membership consists of critical care investigators dedicated to the mission and vision of the CCPTN and is open to anyone expressing an interest in contributing to high-level research. Network member sites represent the breadth of U.S. critical care practice environments. In addition, network members include individuals with demonstrated expertise in patient safety, administration, research design, grantsmanship, database management, peer review, and scientific writing. In 2015, there were more than 100 site investigators from around the United States and Canada. Projects to date have yielded numerous abstracts, platform presentations, and peer-reviewed publications in high-impact journals. The CCPTN has expanded to form collaborations with researchers in the United Kingdom, Australia, and New Zealand. The CCPTN has identified new potential partnerships and field-based areas for inquiry. Numerous opportunities for continued growth and scientific inquiry in the field of critical care pharmacotherapy research exist for the CCPTN to foster in the coming years. Conclusion. The CCPTN has been a successful model for practice-based pharmacotherapy research and assists its members in expanding critical care pharmacotherapy knowledge. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
30. 950: CRITICAL CARE PHARMACIST ATTITUDES AND PERCEPTIONS OF NEUROMUSCULAR BLOCKER INFUSIONS IN ARDS.
- Author
-
Devlin, John, Train, Sarah, Burns, Karen E.A., Massaro, Anthony, Vasseur, John, Selvan, Kavitha, Kress, John, and Erstad, Brian
- Subjects
- *
PHARMACISTS' attitudes , *ADULT respiratory distress syndrome , *CRITICAL care medicine , *CRITICALLY ill , *COVID-19 pandemic , *MUSCLE weakness - Abstract
B Conclusions: b Most pharmacists agree NMBI infusions in ARDS are best reserved until after trials of deep sedation or proning. For COVID+ ARDS patients, few respondents felt any of the following were very/extremely important reasons for NMBI initiation: reduced self-extubation and COVID aerosolization exposure during reintubation 8(6%) or reduced sedative use during shortages 8(6%). B Introduction: b In the face of the COVID pandemic, and recent evidence and practice guidelines surrounding neuromuscular infusion (NMBI) use during ARDS, the practices/perceptions of ICU pharmacists regarding NMBI use during ARDS may not be evidence-based. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.